title: [Eosinophilic fasciitis and metastatic choroïdal melanoma: a paraneoplastic syndrome?].
abstract: BACKGROUND
  Eosinophilic fasciitis (EF) is a rare inflammatory and fibrosing disorder with clinical, biological and histological characteristics. It has sometimes been reported with hematologic malignancy, but has never been associated with malignant uveal melanoma.
  
  
  METHODS
  A 67-year-old woman with choroidal melanoma was found to have metastatic skeletal extension of her melanoma while she developed swelling and pain in the lower limbs. Histologic examination confirmed an EF and oral corticosteroid treatment was started. A treatment for the ophthalmologic and skeletal extension of her melanoma was initiated. The paraneoplastic character of this EF was entertained.
  
  
  CONCLUSIONS
  The simultaneous occurrence of EF and metastatic skeletal melanoma is suggestive of the possibility of EF constituting a paraneoplastic syndrome.
authors.affiliation: Service de médecine interne B, CHI de Poissy, 20, rue Armagis, 78100 St-Germain-en-Laye, France. cveyssier@chi-poissy-st-germain.fr
authors.forename: C
authors.initials: C
authors.lastname: Veyssier-Belot
authors.forename: P
authors.initials: P
authors.lastname: Zuech
authors.forename: L
authors.initials: L
authors.lastname: Lumbroso-Le Rouic
authors.forename: G
authors.initials: G
authors.lastname: Récanati
authors.forename: R
authors.initials: R
authors.lastname: Dendale
mesh_terms: D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary / Q000601:surgery; D002830:Choroid Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D004802:Eosinophilia / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D005208:Fasciitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D008545:Melanoma / Q000150:complications* / Q000188:drug therapy / Q000532:radiotherapy; D008875:Middle Aged; D010257:Paraneoplastic Syndromes; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D018931:Antineoplastic Agents, Hormonal; D007457:Iodine Radioisotopes; D011241:Prednisone